GANZETTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.786
EU - Europa 2.631
AS - Asia 1.957
SA - Sud America 477
Continente sconosciuto - Info sul continente non disponibili 147
AF - Africa 139
OC - Oceania 7
Totale 10.144
Nazione #
US - Stati Uniti d'America 4.687
SG - Singapore 531
IT - Italia 475
VN - Vietnam 427
UA - Ucraina 414
BR - Brasile 391
RU - Federazione Russa 365
CN - Cina 363
DE - Germania 248
FR - Francia 242
IE - Irlanda 217
SE - Svezia 215
TR - Turchia 164
DK - Danimarca 141
FI - Finlandia 126
HK - Hong Kong 117
GB - Regno Unito 99
KR - Corea 80
CI - Costa d'Avorio 78
BD - Bangladesh 76
IN - India 74
CA - Canada 39
MX - Messico 37
AR - Argentina 33
ZA - Sudafrica 23
IQ - Iraq 19
JP - Giappone 19
PL - Polonia 17
ES - Italia 15
CO - Colombia 14
ID - Indonesia 14
MA - Marocco 13
NL - Olanda 13
EC - Ecuador 11
JM - Giamaica 10
PK - Pakistan 10
UZ - Uzbekistan 10
RO - Romania 9
AU - Australia 7
KZ - Kazakistan 7
MY - Malesia 7
PY - Paraguay 7
VE - Venezuela 7
CL - Cile 6
LT - Lituania 6
CH - Svizzera 5
DZ - Algeria 5
EU - Europa 5
KE - Kenya 5
PH - Filippine 5
HR - Croazia 4
PE - Perù 4
TH - Thailandia 4
AT - Austria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
NP - Nepal 3
PT - Portogallo 3
SA - Arabia Saudita 3
SN - Senegal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
OM - Oman 2
SM - San Marino 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LY - Libia 1
MT - Malta 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 10.002
Città #
Ashburn 625
Jacksonville 402
Chandler 378
Fairfield 315
Singapore 300
Dallas 286
Council Bluffs 216
Dublin 216
Boardman 192
Wilmington 146
New York 144
San Jose 137
Ho Chi Minh City 135
Woodbridge 134
Houston 127
Hong Kong 117
Seattle 109
Beijing 94
Cambridge 94
Hanoi 94
Los Angeles 86
San Mateo 86
Lawrence 82
Princeton 82
Abidjan 78
The Dalles 78
Centro 74
Lauterbourg 69
Munich 60
Ann Arbor 50
Milan 50
Moscow 49
São Paulo 49
Hefei 43
Buffalo 37
Turku 35
London 31
San Diego 31
Turin 31
Orem 29
Da Nang 28
Haiphong 26
Pune 25
Rome 22
Des Moines 20
Porto 19
Guangzhou 18
Helsinki 18
Shanghai 18
Marche 16
Santa Clara 16
Johannesburg 14
Phoenix 13
Rio de Janeiro 13
Warsaw 13
Chicago 12
Miano 12
Norwalk 12
Chennai 11
Atlanta 10
Boston 10
Denver 10
Montreal 10
Tokyo 10
Toronto 10
Wuhan 10
Kilburn 9
Naples 9
Poplar 9
Ancona 8
Manchester 8
Mexico City 8
Tashkent 8
Baghdad 7
Belo Horizonte 7
Brooklyn 7
Charlotte 7
Frankfurt am Main 7
Jiaxing 7
Kolkata 7
Thái Bình 7
Amsterdam 6
Cagliari 6
Civitanova Marche 6
Guarulhos 6
Jinhua 6
Kingston 6
Salvador 6
Almaty 5
Bauru 5
Biên Hòa 5
Bogotá 5
Bắc Giang 5
Dhaka 5
Elk Grove Village 5
Fortaleza 5
Hanover 5
Hải Dương 5
Kyiv 5
Madrid 5
Totale 6.004
Nome #
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 223
Active inflammatory biomarkers in oral lichen planus 205
Adipochine e citochine proinfiammatorie nella psoriasi: ruolo modulante di Etanercpet 199
A patient with psoriasis and vitiligo treated with etanercept 180
Adalimumab modulates angiogenesis in psoriatic skin 175
Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis 164
Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial 164
A non-responsive chronic autoimmune urticaria in a 12-year-old autistic girl treated with cyclosporin. 163
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 161
Homocysteine plasma levels in psoriasis patients: our experience and review of the literature 158
T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: At the origin of the problem 157
TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in Cutaneous Mesenchymal Stem Cells of psoriasis patients. 156
Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases 152
Tossicità cutanea da inibitori dell’Epidermal Growth Factor Receptor (EGFR): valutazione clinico-istologica ed approccio terapeutico 152
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 152
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 151
Biologic Therapy in Psoriasis: Safety Profile 147
The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. 146
Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. 145
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 145
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 144
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 144
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 144
CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept. 140
Certolizumab pegol for the treatment of psoriasis 140
Dermoscopic features of conjunctival melanocytic lesions 139
Alopecia Areata: a possible extraintestinal manifestation of Crohn's disease. 137
Skin features in myotonic dystrophy type 1: An observational study 136
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 135
Response to letter to the editor: 'a precise knowledge of ozonated oils will help to define the favourable and peculiar properties of these functional dermatological matrices' 135
Purely cutaneous Langerhans' cell histiocytosis in an adult woman 131
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 131
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 130
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region 130
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 130
Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives 128
Primary cutaneous large cell lymphoma CD30+: a case-based review 127
Factitious disorders in adults: two cases of unusual skin ulcers 126
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines 124
The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients 123
The successful off-label use of photodynamic therapy for classic Porokeratosis of Mibelli:case report" 122
Doxycycline-Isoniazid: a new therapeutic association for recalcitrant acne agminata 122
Microvessel density and VEGF, HIF-1α expression in primary oral melanoma: correlation with prognosis 120
Relapsing acute generalized exanthematous pustolosis: a guess. 119
Effect of Allium Cepa-Allantoin-Pentaglycan Gel on Skin Hypertrophic Scars: Clinical and Video-Capillaroscopic Results of an Open-Label, Controlled, Nonrandomized Clinical Trial. 114
Lifelong widespread warts associated with human papillomavirus type 70/85: a new diagnostic entity? 114
Hidradenoma papilliferum: diagnostic challenge 113
Mycosis Fungoides-like Eruption and Infliximab 113
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 113
The switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group 111
Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy. 110
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 109
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes. 109
Use of infliximab in toxic epidermal necrolysis: a still opened challenge 109
Lesional skin chemokine CTAK/CCL27 expression in mycosis fungoides and disease control by IFN-A and PUVA therapy. 108
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 108
Insulin resistance, serum insulin and HOMA-R 107
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 107
The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis. 105
Hemangioma in POEMS syndrome:an atypical clinical and histological presentation 103
Treatment of focal idiopathic hyperhidrosis with botulinum toxin type-A: clinical predictive factors of relapse free survival 98
Normolipemic plane xanthomatosis with acute development preceding the clinical onset of rheumatoid arthritis 97
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 97
Cutaneous CCL27 expression in early-stage mycosis fungoides: its role in the balance between the tumoral infiltrate and anti-tumoral immune response, and prognostic utility as a predictor of recurrence. 96
Non-alcoholic fatty liver disease and psoriasis: So far, so near 95
Osteopontin: a new facilitating factor in alopecia areata pathogenesis? 94
Videocapillaroscopic pattern of Alopecia Areata before and after diphenylciclopropenone treatment. 94
VEGF, survivin and NOS overexpression in psoriatic skin: Critical role of nitric oxide synthases 93
Rosacea: could topical azelaic acid and oral tetracyclines modify videocapillaroscopic pattern? 93
Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: Results of a retrospective analysis 92
Reciprocal altered expression of E-Cadherin in mucous membrane pemphigoid. 91
Phototherapy in Dermatology 89
In vitro activity of the lipopetide derivative (Pal-lys-lysNh2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes 88
La qualità della vita nel paziente psoriasico: esperienza di due anni del centro Psocare della Clinica Dermatologica di Ancona. 87
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background 87
Possibile ruolo delle molecole di adesione cellula-cellula nei meccanismi patogenetici del pemfigo volgare 85
Possibile ruolo delle molecole di adesione nei meccanismi patogenetici delle lesioni bollose nei pemfigoidi 82
Topical ozonated oil versus hyaluronic gel for the treatment of partial- to full-thickness second-degree burns: A prospective, comparative, single-blind, non-randomised, controlled clinical trial. 82
Metabolic Features in Psoriasis 81
SERUM LEVELS OF TH1 AND TH2 CHEMOKINES IN CUTANEOUS T CELL LYMPHOMAS (CTCL) 77
Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo 72
Inflammatory bowel diseases and the skin: a monography 69
Totale 10.144
Categoria #
all - tutte 48.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022568 0 166 17 22 4 31 31 44 32 47 63 111
2022/20231.124 103 142 103 82 78 124 1 77 295 6 85 28
2023/2024707 119 17 51 91 109 165 15 23 2 17 7 91
2024/20251.203 181 104 30 14 57 20 103 28 269 77 149 171
2025/20263.450 256 258 277 401 376 239 537 289 253 259 120 185
2026/2027335 236 99 0 0 0 0 0 0 0 0 0 0
Totale 10.144